StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS – Get Rating) in a report published on Tuesday morning. The firm issued a sell rating on the stock.
Milestone Scientific Stock Performance
Shares of Milestone Scientific stock opened at $0.99 on Tuesday. The company’s fifty day simple moving average is $0.84 and its 200-day simple moving average is $0.71. The company has a market cap of $69.30 million, a price-to-earnings ratio of -9.00 and a beta of 1.38. Milestone Scientific has a 1 year low of $0.41 and a 1 year high of $1.27.
Milestone Scientific (NYSE:MLSS – Get Rating) last posted its quarterly earnings results on Thursday, May 11th. The company reported ($0.02) earnings per share for the quarter. Milestone Scientific had a negative return on equity of 75.26% and a negative net margin of 93.22%. The business had revenue of $2.60 million for the quarter.
Institutional Trading of Milestone Scientific
Milestone Scientific Company Profile
Milestone Scientific, Inc is a biomedical technology research and development company, which patents, designs, and develops diagnostic and therapeutic injection technologies and instruments. It operates through the following segments: Dental, Medical, and Corporate. The Corporate segment refers to executive management, investor relations, patents, trademarks, licensing agreements, new instruments developments, financing activities, and public company compliance costs.
Featured Articles
- Get a free copy of the StockNews.com research report on Milestone Scientific (MLSS)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.